Phase Ib Study to Determine MTD of AZD1775 Monotherapy in Patients With Locally Advanced or Metastatic Solid Tumours.
Clinical trial NCT02610075 · COMPLETED
Trial details
- NCT number
- NCT02610075
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-01
- Primary completion
- 2018-04-26
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.